electroCore announced the United States Patent and Trademark Office has issued a patent related to a system for stimulating a nerve target in the head or neck of a patient for treatment of various disorders, such as primary headache. U.S. Patent No. 11,839,764 entitled “Systems and Methods for Treating a Medical Condition with an Electrical Stimulation Treatment Regimen” was issued on December 12, 2023, and is generally related to a system including a downloadable software program on, for example, a mobile device, that is configured to control a parameter of the electrical impulses delivered by a stimulator for targeting nerves in the head or neck of a patient to treat various disorders such as primary headache, among others.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ECOR:
- electroCore Expands Intellectual Property Portfolio for Nerve Stimulation Technology
- electroCore to host virtual analyst day
- Dr. Peter Staats to Host Analyst Day on the Science Behind gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) on Tuesday, November 21, 2023
- electroCore price target raised to $11 from $10 at H.C. Wainwright
- electroCore boosts year revenue view to $15M – $15.5M from prior $14M -$15M